Vident Advisory, LLC Natera, Inc. Transaction History
Vident Advisory, LLC
- $3.62 Trillion
- Q2 2024
A detailed history of Vident Advisory, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Vident Advisory, LLC holds 1,910 shares of NTRA stock, worth $247,975. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,910
Previous 3,398
43.79%
Holding current value
$247,975
Previous $311 Million
33.45%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding NTRA
# of Institutions
504Shares Held
120MCall Options Held
412KPut Options Held
270K-
Vanguard Group Inc Valley Forge, PA11.3MShares$1.46 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$879 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY6.07MShares$788 Million0.06% of portfolio
-
Fred Alger Management, LLC New York, NY5.26MShares$683 Million2.83% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.46MShares$579 Million2.34% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $12.6B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...